Patents for C12R 1 - Micro-organisms (92,025)
11/1999
11/03/1999EP0953645A2 Transcription factor controlling phenylpropanoid biosynthesis pathway
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953640A2 cDNA sequences of genes involved in the induction of resistance in plants
11/03/1999EP0953045A1 Method of recovering a biological molecule from a recombinant microorganism
11/03/1999EP0953044A2 Gene for adenylate cyclase and its use
11/03/1999EP0953038A1 Novel process for the propagation of b. pertussis
11/03/1999EP0953037A1 A mutant e. coli strain with increased succinic acid production
11/03/1999EP0952984A1 Two-component signal tranducing system from staphylococcus aureus
11/03/1999EP0952981A1 Method for producing a correctly folded, biological active recombinant protein
11/03/1999EP0952979A1 Production of xylanase and cellulase in b. subtilis
11/03/1999EP0693121A4 Monoclonal antibody 88bv59, subclones and method of making
11/03/1999EP0401303B2 Novel human tissue plasminogen activator variants and processes
11/03/1999EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999CN1234075A Retroviral vector
11/03/1999CN1234074A Method for preparing 2-hydroxy 4-methylthio butyric acid using nitrilase
11/03/1999CN1234070A Peniophora phytase
11/03/1999CN1233938A Pesticidal agent
11/02/1999US5977323 Purifying inflammatory cytokine/chemokine by immunoaffinity chromatography; complexing chemokine to anti-gro antibodies bound to matrix, eluting chemokine
11/02/1999US5977320 Antibody to novel human phosphorylase kinase gamma subunit
11/02/1999US5977315 Murine anti-idiotype antibody 3H1
11/02/1999US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999US5977291 Copolyesters and methods of their production
11/02/1999US5977250 Latex of polyhydroxyalkanoate
11/02/1999US5977065 Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form
11/02/1999US5976873 Nucleic acid sequences controlling lung cell-specific gene expression
11/02/1999US5976863 Process for the preparation of substituted methoxyphenols and microorganisms suitable for this purpose
11/02/1999US5976862 Process for obtaining DNA, RNA, peptides, polypeptides, or proteins, by recombinant DNA technique
11/02/1999US5976861 Proteins for the isolation of antibodies.
11/02/1999US5976856 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide
11/02/1999US5976855 Method of preparing a variant of a lipolytic enzyme
11/02/1999US5976848 Method of identifying potential fungicides using dihydroorotate dehydrogenase inhibition assay
11/02/1999US5976844 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity
11/02/1999US5976843 Culturing escherichia coli in medium comprising saccharose, ammonium sulfate, potassium sulfate, magnesium sulfate hydrates, iron sulfate hydrate, yeast autolyzate, and water; for high yield and stable plasmid without antibiotics
11/02/1999US5976841 Proteins having fibrinolytic and coagulation--inhibiting properties
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976833 Relates to a method of producing protein or peptide by the culture of recombinant cells.
11/02/1999US5976831 Therapeutic compounds, and more particularly to soluble and membrane-bound forms of a low-affinity receptor for human immunoglobulin g, nucleic acids encoding the same. diagnostic uses of such receptors.
11/02/1999US5976816 Cell tests for alzheimer's disease
11/02/1999US5976787 Possible sites for gene inactivation to attenuate mdv field isolates for vaccine purposes.
11/02/1999US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999US5976530 Peptide plasminogen activators
11/02/1999US5976376 Sewage treatment process
11/02/1999US5975095 Enzymatic detergent composition and method for degrading and removing bacterial cellulose and glycerides
11/02/1999CA2171331C Synthesis of catechol from biomass-derived carbon sources
11/02/1999CA2144055C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/02/1999CA2119443C Human cyclin e
11/02/1999CA2066263C Tsh receptor
11/02/1999CA2053911C Recombinant antibody-toxin fusion protein
11/02/1999CA2002788C Adp glucose-pyrophosphorylase
11/02/1999CA1340813C Bacillus thuringiensis isolate denoted b.t. ps81f active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
11/02/1999CA1340812C Bacillus thuringiensis isolate denoted b.t. ps81gg, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
11/02/1999CA1340809C Process for producing a novel antifungal product from pediococcus sp.
10/1999
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054454A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054432A1 Method for producing and extracting aromatic compounds
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999032653A9 Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
10/28/1999WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3
10/28/1999DE19818665A1 High yield oxidation of trimethyl-cyclohexene compounds, especially ionones, to hydroxy or oxo derivatives
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999CA2329763A1 Method for producing and extracting aromatic compounds
10/28/1999CA2325604A1 Mutants of the mycobacterium species and the use thereof for screening for antibiotic vectors
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0951563A1 A new eia test using non-dentured hiv antigen for early detection of hiv infection
10/27/1999EP0951561A1 Enzymatic processes for preparing (s)-cyanohydrins
10/27/1999EP0951538A2 PARTIAL SEQUENCES OF PURINE BIOSYNTHESIS GENES FROM $i(ASHBYA GOSSYPII) AND THEIR USE IN THE MICROBIAL RIBOFLAVIN SYNTHESIS
10/27/1999EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999EP0951534A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
10/27/1999EP0951469A1 Novel compounds
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233285A Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1232872A Overproduction of riboflavin in yeast
10/27/1999CN1045997C Anti-coccidium agent composition and its preparation
10/27/1999CN1045995C Method of inducing lysine overproduction in plants
10/27/1999CN1045994C Modification of plant viruses or their effects
10/26/1999US5973230 Pinosylvine synthase genes
10/26/1999US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999US5973116 Compounds for targeting
10/26/1999US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999US5972872 Enzyme preparation with cellulytic activity
10/26/1999US5972708 Plasmid stabilization
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972691 Producing polyamine-epihalohydrin resin in aqueous solution by reacting epihalohydrin with polyamine prepolymer, removing byproduct halide ion residue by bioremediation with microorganism or enzyme isolated from microorganism
10/26/1999US5972687 Toxin gene from Xenorhabdus nematophilus
10/26/1999US5972683 Mutant type subtilisin YaB and its application
10/26/1999US5972676 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/26/1999US5972673 Enzyme for phage resistance
10/26/1999US5972666 Assembly-deficient herpesvirus vaccine
10/26/1999US5972665 Pyrodictium pullulanase
10/26/1999US5972663 Microorganism strain that overexpresses a gene which encodes a protein directly suitable for secreting antibiotics, or other toxic substances, out of the cell, the strain also has deregulated metabolism for increased l-cysteine production
10/26/1999US5972659 Introducing into e. coli a heterologous plasmid expression vector coding for the tobacco mosaic virus protein coat and a pathogen's epitope, separating fusion protein and lowering ph to form a self-aggregated protein and hapten for vaccines
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999US5972642 Cultivating a strain of phaffia rhodozyma with specific oxygen transfer rate in a shake flask with biotin or desthiobiotin in the media; culturing under growth limiting conditions to increase astaxanthin production; harvesting